Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 11 to 14 amino acid residues in defined sequence
Patent
1983-08-12
1987-08-11
Phillips, Delbert R.
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
11 to 14 amino acid residues in defined sequence
530328, 530329, C07K 706, C07K 708
Patent
active
046862820
ABSTRACT:
Polypeptides which are immunotherapeutic agents which block immune complex binding to immunoglobulin Fc receptors are produced.
REFERENCES:
patent: 3928306 (1975-12-01), Uchiyama et al.
patent: 3971736 (1976-07-01), Wagner et al.
patent: 4107298 (1978-08-01), Luning
patent: 4161522 (1979-07-01), Hamburger
patent: 4171299 (1979-10-01), Hamburger
patent: 4250086 (1981-02-01), Heavner
patent: 4308181 (1981-12-01), McGregor
patent: 4309340 (1982-01-01), Sarantakis
patent: 4310456 (1982-01-01), Goldberg
patent: 4311639 (1982-01-01), Ganfield et al.
patent: 4341761 (1982-07-01), Ganfield et al.
patent: 4353822 (1982-10-01), Goldberg
patent: 4369137 (1983-01-01), Heavner
patent: 4374765 (1983-02-01), McGregor
patent: 4377516 (1983-03-01), Goldberg
patent: 4392997 (1983-07-01), Goldberg
patent: 4395404 (1983-07-01), Low
patent: 4415493 (1983-11-01), Weigle
patent: 4426324 (1984-01-01), Meienhofer
patent: 4428938 (1984-01-01), Kisfaludy et al.
patent: 4438029 (1984-03-01), Erickson et al.
Johnson et al., (J. Immunol., 117, 1491 (1975)).
Boackle et al., (Nature, 282, 742 (1979)).
Prystowksy et al., (Biochemistry, 20, 6349 (1981)).
Lukas et al., (J. Immunol., 127, 2555 (1981)).
Burton et al., Nature, 288, 338 (1980).
Veretennikova et al., Int. J. Peptide Protein Res., 17, 430 (1981).
Morgan et al., (Proc. Natl. Acad. Sci., USA, 79, 5388 (1982)).
Ciccimarra et al., (Proc. Natl. Acad. Sci., USA, 72, 208 (1975)).
Stanworth, Mol. Immunol., 19, 1245 (1982).
Hamburger, Science, 189, 389 (1975).
Plummer et al., Fed. Proc., 42, 713 (1983).
Hamburger, Immunology, 38, 781 (1979).
Biochem. J., 180, 665 (1979).
Biochem. J., 181, 623 (1979).
Barnett-Foster et al., Mol. Immunol., 19, 407 (1982).
Barnett-Foster et al., J. Immunol., 120, 407 (1978).
Takatsu et al., J. Immunol., 114, 1838 (1975).
Dorrington et al., Immunol. Rev., 41, 3 (1978).
Perex-Montfort, Mol. Immunol., 19, 1113 (1982).
Kuehl et al., Science, 210, 978 (1980).
Goodwin, Clin. Immunol. Immunopath., 15, 106 (1980).
Stenson et al., Immunol., 125, 1 (1980).
Leung et al., J. Immunol., 129, 1742 (1982).
Fischer et al., J. Immunol., 126, 1452 (1981).
Klein et al., Immunol., 48, 337 (1983).
Goodwin et al., Cancer Immunol. Immunother., 8, 3 (1980).
Samuelsson, Science, 220, 568 (1983).
Weiss et al., J. Immunol., 129, 309 (1982).
Fantone, J. Pathol., 107, 397 (1982).
Perex et al., Textbook Rheumatology, vol. 1, W. B. Saunders, Philadelphia, 1981 (pp. 179-194).
Dreisn et al., N. Engl. J. Med., 298, 358 (1978).
Lawrence et al., N. Engl. J. Med., 302, 1187 (1980).
Holdsworth, J. Immunol., 130, 735 (1983).
Striker, J. Exp. Med., 149, 127 (1979).
Kumar in Pathologic Basis of Disease, eds. S. L. Robbins & R. S. Cotran, (W. B. Saunders; Philadelphia, 1979), p. 304.
Melwicz et al., Clin. Exp. Immunol., 49, 364 (1982).
Spiegelberg et al., 42, 124 (1983).
Scott et al., Fed. Proc., 42, 129 (1983).
McMillan, N. Engl. J. Med., 304, 1135 (1981).
Fehr et al., (N. Engl. J. Med., 306, 1254 (1982)).
Imbach et al., (Lancet, Jun. 6, 1981, p. 1228).
Oberbarnscheidt et al., Immunol., 35, 151 (1978).
Kolsch et al., Immunol. Rev., 49, 61 (1980).
Fridman et al., Immunol. Rev., 56, 51 (1981).
Bich-Thuy, J. Immunol., 129, 150 (1982).
Smolen et al., J. Immunol., 129, 10150 (1982).
Goeken et al., Hum. Immunol., 6, 79 (1983).
Kabelitz et al., Eur. J. Immunol., 12, 687 (1982).
Sakane et al., Proc. Natl. Acad. Sci. U.S.A., 75, 3464 (1978).
Miyasaka et al., J. Clin. Invest., 66, 928 (1980).
James et al., J. Clin. Invest., 66, 1305 (1980).
Immunetech, Inc.
Phillips Delbert R.
LandOfFree
Immunotherapeutic polypeptide agents which block immune complex does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunotherapeutic polypeptide agents which block immune complex , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunotherapeutic polypeptide agents which block immune complex will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-403458